CME Group Inc. (CME) Price Target Analysis
Wall Street analyst price targets, ratings consensus & upside potential · Updated May 1, 2026
Current Price
$286.82
Price Target
$320.25
Target Range
$302.00 — $353.00
Analyst Rating
Hold
Forward P/E23.5x
Trailing P/E25.7x
Forward PEG1.71
Implied Growth+4.5%
Median Target$313.00
Analyst Spread15.9%
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Bear Case
$302
+5.3%
Consensus
$320
+11.7%
Bull Case
$353
+23.1%
Valuation Model TargetsConfidence: 66/100
Bear$204
Base$278
Bull$379
CME Price Target Analysis
Updated May 6, 2026As of May 6, 2026, CME Group Inc. (CME) has a Wall Street consensus price target of $320.25, based on estimates from 35 covering analysts. With the stock currently trading at $286.82, this represents a potential upside of +11.7%. The company has a market capitalization of $104.06B.
Analyst price targets range from a low of $302.00 to a high of $353.00, representing a 16% spread in expectations. The median target of $313.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 13 analysts rating the stock as a Buy or Strong Buy,17 rating it Hold, and 5 rating it Sell or Strong Sell. The mixed ratings reflect uncertainty about near-term direction.
From a valuation perspective, CME trades at a trailing P/E of 25.7x and forward P/E of 23.5x. The forward PEG ratio of 1.71 indicates reasonable valuation for growth. Analysts expect EPS to grow +4.5% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $277.64, with bear and bull scenarios of $204.06 and $379.24 respectively. Model confidence stands at 66/100, reflecting moderate uncertainty in projections.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Financial Services stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside+15.9%
Avg Forward P/E19.5x
Peers with Coverage10 / 10
| Company | Market Cap | Price | Target | Upside | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 ICEIntercontinental Exchange, Inc. | $88.0B | $155.28 | $195.71 | +26.0% | Buy | 19.4x | 36 |
 CBOECboe Global Markets, Inc. | $36.0B | $343.98 | $296.00 | -13.9% | Hold | 27.4x | 31 |
 NDAQNasdaq, Inc. | $50.6B | $89.00 | $114.60 | +28.8% | Buy | 22.6x | 36 |
 MKTXMarketAxess Holdings Inc. | $5.6B | $151.29 | $195.60 | +29.3% | Hold | 18.5x | 23 |
 MSCIMSCI Inc. | $42.3B | $580.88 | $674.33 | +16.1% | Buy | 29.6x | 27 |
 SPGIS&P Global Inc. | $125.5B | $423.87 | $548.11 | +29.3% | Buy | 21.6x | 28 |
 FDSFactSet Research Systems Inc. | $9.4B | $219.42 | $277.89 | +26.6% | Hold | 12.4x | 28 |
 TWTradeweb Markets Inc. | $23.5B | $110.21 | $130.20 | +18.1% | Buy | 27.3x | 28 |
 BGCBGC Group, Inc | $4.0B | $11.10 | $11.50 | +3.6% | Buy | 7.8x | 2 |
 VIRTVirtu Financial, Inc. | $4.3B | $50.60 | $48.00 | -5.1% | Hold | 8.4x | 13 |
Upside Potential Comparison
SPGIMKTXNDAQFDSICETWMSCIBGCFull CME Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See CME's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs CME Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare CME vs BRK-A
Side-by-side business, growth, and profitability comparison vs Berkshire Hathaway Inc..
Start ComparisonCME — Frequently Asked Questions
Quick answers to the most common questions about buying CME stock.
What is the CME stock price target for 2026?
CME Group Inc. (CME) has a consensus 12-month price target of $320.25, implying 11.7% upside from $286.82. The 35 analysts covering CME see moderate appreciation potential.
Is CME a buy, sell, or hold?
CME has a consensus rating of "Hold" based on 35 Wall Street analysts. The rating breakdown is mixed, with 17 Hold ratings making up the largest segment. The consensus 12-month price target of $320.25 implies 11.7% upside from current levels.
Is CME stock overvalued or undervalued?
CME trades at a forward P/E of 23.4869x, representing a moderate valuation. With analysts targeting $320.25 (11.7% implied move), the stock appears reasonably valued with upside.
How high can CME stock go?
The most bullish Wall Street analyst has a price target of $353 for CME, while the most conservative target is $302. The consensus of $320.25 represents the median expectation. Our quantitative valuation model projects a bull case target of $379 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
How many analysts cover CME stock?
CME is heavily covered by Wall Street, with 35 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 13 have Buy ratings, 17 recommend Hold, and 5 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the CME stock forecast?
The 12-month CME stock forecast based on 35 Wall Street analysts shows a consensus price target of $320.25, with estimates ranging from $302 (bear case) to $353 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $278, with bear/bull scenarios of $204/$379.
What is CME's fair value based on fundamentals?
Our quantitative valuation model calculates CME's fair value at $278 (base case), with a bear case of $204 and bull case of $379. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 66/100.
What is CME's forward P/E ratio?
CME trades at a forward P/E ratio of 23.5x based on next-twelve-months earnings estimates compared to a trailing P/E of 25.7x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy CME stock?
Wall Street analysts are optimistic on CME, with a "Hold" consensus rating and $320.25 price target (11.7% upside). 13 of 35 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do CME price targets vary so much?
CME analyst price targets range from $302 to $353, a 16% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $320.25 consensus represents the middle ground. Our model's $204-$379 range provides an independent fundamental perspective.